Clinical trials sponsored by Glaukos Corporation
6
Recruiting trials
7
Conditions studied
Phase breakdown
Phase 2 1Phase 3 1Phase 4 2Not applicable 2
Conditions studied
| Condition | Trials |
|---|---|
| Hypertension | 6 |
| Glaucoma | 3 |
| Glaucoma, Open-Angle | 2 |
| Ocular Hypertension (OH) | 1 |
| Ocular Hypertension (OHT) | 1 |
| Open Angle Glaucoma (OAG) | 1 |
| Phacoemulsification Cataract Surgery | 1 |
Recruiting trials led by Glaukos Corporation
- Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
- Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
- Travoprost Intraocular Implant + iStent Infinite
- Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Common questions
How many trials is Glaukos Corporation recruiting for?
Glaukos Corporation is the lead sponsor of 6 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.